Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

A--Drug Manufacturing and Formulation Program (DMFP)

Awarded
75N95024R00077Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Four indefinite delivery/indefinite quantity contracts worth up to $49,999,999 each were awarded on May 4, 2026, under the Drug Manufacturing and Formulation Program, with an ordering period spanning ten years from May 4, 2026, to May 3, 2036. Each contract was issued simultaneously with a first task order effective immediately through July 3, 2026, for a firm-fixed price of $5,000 per awardee. The solicitation, numbered 75N95024R00077, was posted on May 5, 2026, under NAICS code 325412 for pharmaceutical and medicinal product manufacturing, with no set-aside provisions applied. The contracts were awarded by the National Institutes of Health, specifically the National Institute on Drug Abuse within the Department of Health and Human Services, based in Bethesda, Maryland, and the work is to be performed in Kansas City, Missouri. Primary point of contact is Rieka N. Plugge, with secondary contact Kelly Dempsey, both reachable through NIH email addresses.

General Info

Four IDIQ contracts worth nearly $50M each for drug manufacturing, 2026–2036, initial $5K task orders, NIH NIDA awarded.

Contract Value

$0

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Kansas City, MO, USA

Set-Aside

NONE

Awardee

MRIGLOBAL

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

8 updates
PhaseAwarded
Posted

Presolicitation

Notice updated

Response deadline changed from Jun 16, 2024 to May 20, 2024. The notice description changed.

Notice updated

Response deadline changed from May 20, 2024 to May 23, 2024. The notice description changed.

Deadline changed

Response deadline changed from May 23, 2024 to May 31, 2024.

Notice updated

Response deadline changed from May 31, 2024 to Jun 4, 2024. The notice description changed.

Notice updated

Response deadline changed from Jun 4, 2024 to Jun 7, 2024. The notice description changed.

Type Changed

Presolicitation → Solicitation

Notice updated

The notice title changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Deadline changed

Response deadline changed from Jul 22, 2024 to Jul 29, 2024.

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida
Contacts2 people available
OfficeBethesda, MD, 20892, USA
Office AddressBethesda, MD, 20892, USA
Contacts
PLUGGE RIEKA N
Kelly Dempsey

Full Description

Show more

Four (4) Indefinite Delivery/Indefinite Quantity (IDIQ) type contracts with a maximum ordering value of $49,999,999.00 and an ordering period from May 4, 2026 through May 3, 2036, were awarded on May 4, 2026. Concurrently, the first task orders were issued to each awardee with an effective date of May 4, 2026 through July 3, 2026, in the firm-fixed price amount totaling $5,000.00. 

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
Solicitation # 36E79727R0039
The Department of Veterans Affairs Enterprise Procurement Office intends to issue Request for Proposal 36E79727R0039 for an unrestricted procurement of Latanoprost Ophthalmic Solution. This contract will establish an uninterrupted source of supply for the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. Distribution will be managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The award will be granted to a single responsible offeror for a base period of one year with four pre-priced one-year option periods. The solicitation is expected to be issued in commercial item format per FAR Part 12 on approximately October 21, 2026, with a tentative closing date of November 4, 2026. Strict labeling and packaging requirements apply to this procurement. Offerors must provide a unique NDC number and the exact drug name as it appears on the label. The contractor's label must be the only one on the product, and affixing labels over existing ones is prohibited; however, the product must allow VA labels to adhere securely on top. Additionally, vendors must comply with the American Academy of Ophthalmology’s recommended uniform color-coding system for the caps and labels of all topical ocular medications. This acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements, and all electronic communications and submissions will be handled via SAM.gov.
Nac Pharmaceuticals (36E797)

POSTED

1 day ago

DEADLINE

in 13 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida

Same awarding agency

NAICS: 541714
New
Federal
Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories
Solicitation # 75N98026R00175
The National Institutes of Health is issuing a Sources Sought Notice to identify qualified research and development firms, small businesses, and subcontractors capable of providing biobanking, laboratory analytics, and informatics services for NIH biorepositories starting in fiscal year 2028. The primary objective is to support the operation and potential consolidation of repositories, specifically including the NIDA Center for Genetic Studies and the NIH Brain Development Cohorts Biobank. This is a market research effort to determine the availability of technically capable sources and to inform the government's decision on the appropriate acquisition method and potential small business set-asides. The required scope of work involves the secure storage and tracking of at least 3.5 million biospecimens, comprehensive data curation and management using auditable LIMS, and advanced laboratory capabilities such as high-throughput sequencing and CRISPR/Cas9 gene editing. Additionally, the contractor must provide informatics support to develop and maintain web portals, APIs, and secure cyberinfrastructure compliant with FISMA standards. Interested parties must submit a detailed capability statement, including experience, personnel qualifications, and facility descriptions, to the designated contract specialists by October 20, 2026.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

2 days ago

DEADLINE

in 17 days
View Details
NAICS: 541690
Federal
Modification to Extend Services for Scientific, Operations and Administrative Resources (SOAR) Contract Program
Solicitation # OLAO-SSD-SOAR-NOI
The National Institutes of Health (NIH) intends to negotiate and award non-competitive modifications to extend the Scientific, Operations and Administrative Resources (SOAR) contract program. This program consists of five indefinite-delivery, indefinite-quantity (IDIQ) contracts held by Axle Informatics LLC, Gap Solutions Inc., Kelly Services Inc., Guidehouse Digital LLC, and 22nd Century Technologies Inc. The primary objective is to ensure continuity of specialized scientific professional services across 29 NIH organizations, including the Office of the Director, 27 Institutes and Centers, and ARPA-H, while the agency finalizes a strategic procurement consolidation effort and a competitive follow-on acquisition. The proposed extension includes a basic ordering period from June 22, 2026, to June 21, 2027, with two optional six-month extensions extending through June 21, 2028. Additionally, the government seeks to revise FAR 52.216-22 to allow task orders to extend up to 36 months beyond the parent contract end date. While the combined maximum contract ordering value remains unchanged at $3,600,713,546, the estimated total dollar value for orders through the end of the extension is $2,174,615,674. The government projects the award of these modifications in April 2026. The SOAR program provides critical scientific staffing, such as bioinformatics scientists and molecular biologists, to support biomedical research and public health missions. The NIH has cited a critical need for these specific contract holders to avoid disruptions to ongoing research and patient diagnostics. Interested parties may submit capability statements and pricing information by March 5, 2027, although the government currently intends to proceed on a non-competitive basis with the existing holders.
Other Scientific and Technical Consulting Services

POSTED

7 months ago

DEADLINE

in 5 months
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS